Signed in · PRO

Guidance history, every release

Molina Healthcare (MOH) · 8 releases, Oct 23, 2024 to Jul 22, 2026 · rows are metrics, columns are releases

Raised · a change from the previous releaseSame · restated unchanged— · not stated in that releaseEvery value links to its sentence in the filing

Metric	Oct 23, 2024 FY24 Q3	Feb 5, 2025 FY24 Q4	Apr 23, 2025 FY25 Q1	Jul 7, 2025 FY25 Q2	Oct 22, 2025 FY25 Q3	Feb 5, 2026 FY25 Q4	Apr 22, 2026 FY26 Q1	Jul 22, 2026 FY26 Q2
For FY2027
New store embedded earnings	—	—	—	—	—	New“over $11.00 per diluted share”	—	—
For FY2026
Premium Revenue	—	—	—	—	—	New“approximately $42 billion”	Reiterated“approximately $42 billion”	—
Premium Revenue	—	—	—	—	—	New“$42.2B”	—	—
Premium revenue for the full year	—	—	—	—	—	—	—	New“approximately $42 billion”
Total Revenue	—	—	—	—	—	New“$44.5B”	—	—
Adjusted earnings	—	—	—	—	—	New“at least $5.00 per diluted share”	Reiterated“at least $5.00 per diluted share”	Raised“at least $5.25 per diluted share”
Adjusted net income	—	—	—	—	—	—	—	New“$268”
Adjusted Net Income	—	—	—	—	—	New“$256M”	—	—
Adjusted net income (2026)	—	—	—	—	—	—	New“$256”	—
Adjusted net income per diluted share	—	—	—	—	—	—	—	New“$5.25”
Adjusted net income Per Diluted Share (2026)	—	—	—	—	—	—	New“$5.00”	—
Adjusted Pre-tax Margin	—	—	—	—	—	New“0.8%”	—	—
GAAP earnings	—	—	—	—	—	—	New“at least $1.90 per diluted share”	Raised“at least $2.15 per diluted share”
GAAP earnings	—	—	—	—	—	New“at least $3.20 per diluted share”	—	—
GAAP earnings per share	—	—	—	—	—	New“at least $3.20 per diluted share”	—	—
GAAP Net income	—	—	—	—	—	—	—	New“$110”
GAAP Net Income	—	—	—	—	—	New“$164M”	—	—
GAAP Net income (2026)	—	—	—	—	—	—	New“$97”	—
GAAP Net income per diluted share	—	—	—	—	—	—	—	New“$2.15”
GAAP Net income Per Diluted Share (2026)	—	—	—	—	—	—	New“$1.90”	—
Marketplace earnings per share decrease	—	—	—	—	—	—	—	New“a $1.50 decrease related to Marketplace”
Marketplace Segment Earnings Outlook	—	—	—	—	New“reduced exposure to Marketplace, with segment earnings at least break even”	—	—	—
New Store Embedded Earnings	—	New“$7.75 per diluted share”	Raised“$8.65 per diluted share”	—	Reiterated“$8.65 per diluted share”	—	—	—
Preliminary 2026 Outlook for Adjusted Earnings per Share	—	—	—	—	New“expected to approximate the full year 2025 guidance”	—	—	—
Adjusted G&A Ratio	—	—	—	—	—	New“6.4%”	—	—
Diluted weighted average shares	—	—	—	—	—	New“51.1M”	—	—
Diluted weighted average shares outstanding assumption	—	—	—	—	—	—	New“approximately 51.1 million”	Reiterated“approximately 51.1 million diluted weighted average shares outstanding”
Effective Tax Rate	—	—	—	—	—	New“30.0%”	—	—
Excluding Marketplace revision	—	—	—	—	—	—	—	New“$6.75 per share”
GAAP G&A Ratio	—	—	—	—	—	New“6.5%”	—	—
Income tax effect statutory tax rate assumption	—	—	—	—	—	—	New“approximately 26.8%”	—
MCR	—	—	—	—	—	New“92.6%”	—	—
MCR - Marketplace	—	—	—	—	—	New“85.5%”	—	—
MCR - Medicaid	—	—	—	—	—	New“92.9%”	—	—
MCR - Medicare	—	—	—	—	—	New“94.0%”	—	—
Statutory tax rate assumption	—	—	—	—	—	—	—	New“approximately 26.0%”
Year End Total Membership	—	—	—	—	—	New“5.1M”	—	—
Year End Total Membership - Marketplace	—	—	—	—	—	New“220K”	—	—
Year End Total Membership - Medicaid	—	—	—	—	—	New“4.6M”	—	—
Year End Total Membership - Medicare	—	—	—	—	—	New“230K”	—	—
For FY2025
Premium revenue	—	New“approximately $42 billion”	Reiterated“approximately $42 billion”	—	Raised“approximately $42.5 billion”	—	—	—
Premium Revenue	—	New“$42.0B”	—	—	—	—	—	—
Total Revenue	—	New“$44.0B”	—	—	Raised“$44.5B”	—	—	—
Adjusted After-tax Margin	—	New“3.1%”	—	—	—	—	—	—
Adjusted earnings	—	New“at least $24.50 per diluted share”	Reiterated“at least $24.50 per diluted share”	—	Lowered“approximately $14.00 per diluted share”	—	—	—
Adjusted earnings	—	—	—	—	New“approximately $0.35 per diluted share”	—	—	—
Adjusted Earnings per Diluted Share	—	—	—	—	New“approximately $14.00 per diluted share”	—	—	—
Adjusted earnings per share	—	—	—	New“approximately $5.50 per share”	—	—	—	—
Adjusted earnings per share	—	—	—	New“$21.50 to $22.50 per share”	—	—	—	—
Adjusted earnings per share	—	—	New“at least $24.50 per share”	—	—	—	—	—
Adjusted EPS - Diluted	—	New“>$24.50”	—	—	Lowered“~ $14.00”	—	—	—
Adjusted EPS growth	—	—	New“8% growth over the full year 2024”	—	—	—	—	—
Adjusted EPS Growth (as reported)	—	New“8% growth over the full year 2024”	—	—	—	—	—	—
Adjusted EPS Growth (yield, excluding implementation costs)	—	New“approximately 13% growth over 2024”	—	—	—	—	—	—
Adjusted Net Income	—	New“$1,362M”	—	Lowered“$1,163 to $1,217”	Lowered“$742M”	—	—	—
Adjusted net income (2025)	—	—	New“$ 1,325”	—	—	—	—	—
Adjusted net income per diluted share	—	—	—	New“$21.50 to $22.50”	—	—	—	—
Adjusted net income Per Diluted Share (2025)	—	—	New“$ 24.50”	—	—	—	—	—
Adjusted Pre-tax Margin	—	—	—	—	New“2.1%”	—	—	—
Consolidated pre-tax margin	—	—	—	New“just under 4%”	—	—	—	—
GAAP earnings per share	—	—	—	—	New“approximately $11.90 per diluted share”	—	—	—
GAAP earnings per share	—	New“at least $22.50 per share”	Lowered“at least $22.32 per share”	—	—	—	—	—
GAAP EPS	—	New“at least $22.50 per share”	Lowered“at least $22.32 per share”	—	—	—	—	—
GAAP EPS - Diluted	—	New“>$22.50”	—	—	Lowered“~ $11.90”	—	—	—
GAAP Net Income	—	New“$1,251M”	—	Lowered“$1,045 to $1,099”	Lowered“$630M”	—	—	—
GAAP Net income (2025)	—	—	New“$ 1,208”	—	—	—	—	—
GAAP Net income per diluted share	—	—	—	New“$19.32 to $20.32”	—	—	—	—
GAAP Net income Per Diluted Share (2025)	—	—	New“$ 22.32”	—	—	—	—	—
Implied Fourth Quarter Adjusted Earnings per Diluted Share	—	—	—	—	New“approximately $0.35 per diluted share”	—	—	—
Medicaid Contribution to Q4 Adjusted Earnings per Diluted Share	—	—	—	—	New“approximately $3.00 per diluted share”	—	—	—
Medicare and Marketplace Offset to Q4 Adjusted Earnings per Diluted Share	—	—	—	—	New“a loss of approximately $2.65 per diluted share”	—	—	—
Adjusted G&A Ratio	—	New“7.0%”	—	—	Lowered“6.5%”	—	—	—
Diluted weighted average shares	—	New“55.6M”	—	—	Lowered“53.0M”	—	—	—
Diluted weighted average shares outstanding assumption	—	—	New“approximately 54.1 million”	—	—	—	—	—
Effective Tax Rate	—	New“25.3%”	—	—	Lowered“21.7%”	—	—	—
GAAP G&A Ratio	—	New“7.2%”	—	—	Lowered“6.6%”	—	—	—
Implementation Costs for Duals Contract Wins	—	New“approximately $1.00 per diluted share”	—	—	—	—	—	—
Marketplace Membership	—	New“580K”	—	—	—	—	—	—
MCR	—	New“88.7%”	—	—	—	—	—	—
MCR - Marketplace	—	—	—	—	New“89.7%”	—	—	—
MCR - Medicaid	—	—	—	—	New“91.5%”	—	—	—
MCR - Medicare	—	—	—	—	New“91.3%”	—	—	—
Medicaid Membership	—	New“5.0M”	—	—	—	—	—	—
Medicare Membership	—	New“250K”	—	—	—	—	—	—
Statutory tax rate assumption	—	—	New“approximately 23.7%”	—	—	—	—	—
Year End Total Membership	—	New“5.9M”	—	—	—	—	—	—
Year End Total Membership - Marketplace	—	New“580K”	—	—	—	—	—	—
Year End Total Membership - Medicaid	—	New“5.0M”	—	—	—	—	—	—
Year End Total Membership - Medicare	—	New“250K”	—	—	—	—	—	—
For FY2024
Premium revenue	New“approximately $38 billion”	—	—	—	—	—	—	—
Adjusted earnings	New“at least $23.50 per diluted share”	—	—	—	—	—	—	—
Adjusted EPS growth	New“approximately 13%”	—	—	—	—	—	—	—
Adjusted net income	New“$ 1,360”	—	—	—	—	—	—	—
Adjusted net income Per Diluted Share	New“$ 23.50”	—	—	—	—	—	—	—
GAAP Net income	New“$ 1,250”	—	—	—	—	—	—	—
GAAP Net income Per Diluted Share	New“$ 21.59”	—	—	—	—	—	—	—
Diluted weighted average shares outstanding assumption	New“approximately 57.9 million”	—	—	—	—	—	—	—
Statutory tax rate (income tax effect)	New“approximately 25.5%”	—	—	—	—	—	—	—
No period stated
Long-term adjusted EPS growth target	—	—	New“13% to 15%”	—	—	—	—	—
Estimated Non-Recurring Costs for Recently Announced Acquisitions	—	New“approximately $20 million”	—	—	—	—	—	—
Non-recurring acquisition-related costs estimate	—	—	New“approximately $23 million”	—	—	—	—	—

Values in quotation marks are the company’s words. Change labels compare each statement with the same metric and target year in the previous release. HighGravityData does not judge whether guidance was met.